IL-12 immunotherapy

Bristol Myers Squibb pens $475M Dragonfly pact for IL-12 program
Fierce Biotech
Mon, 08/17/20 - 10:34 am
Bristol-Myers Squibb
Dragonfly Therapeutics
IL-12 immunotherapy
DF6002